Setting

Europe Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248434 | Pages: 137

Europe bioanalytical testing services market was valued at $ 806.6 million in 2021 and will grow by 9.0% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 39 tables and 79 figures, this 137-page report “Europe Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country. Based on Molecule Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Small Molecules • Large Molecules o LC-MS Studies o Immunoassays o Other Large Molecule Tests Based Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bioavailability and Bioequivalence Studies • Pharmacokinetics (PK) • Pharmacodynamics (PD) • Absorption, Distribution, Metabolism, Excretion (ADME) • Other Applications By Test Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cell-based Assays o Bacterial Cell-based Assays o Viral Cell-based Assays • Virology Testing o In Vitro Virology Testing o In Vivo Virology Testing o Species-Specific Viral PCR Assays • Serology, Immunogenicity, and Neutralizing Antibodies (SINA) o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies o Viral Serology, Immunogenicity, and Neutralizing Antibodies • Method Development Optimization and Validation (MDOV) • Biomarker Testing • Pharmacokinetic Testing • Other Test Types By Workflow Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sample Preparation o Protein Precipitation o Liquid-liquid Extraction (LLE) • Sample Analysis o Hyphenated Technique o Chromatographic Technique o Electrophoresis o Ligand Binding Assay o Mass Spectrometry o Nuclear Magnetic Resonance • Other Workflow Processes By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Neurology • Infectious Diseases • Gastroenterology • Cardiology • Other Therapeutic Areas By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharma and Biopharma Companies • Contract Development and Manufacturing Organizations (CDMOs) • Contract Research Organizations (CROs) Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	28
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of Europe Market by Molecule Type	42
3.1 Market Overview by Molecule Type	42
3.2 Small Molecules	44
3.3 Large Molecules	45
3.3.1 LC-MS Studies	46
3.3.2 Immunoassays	47
3.3.3 Other Large Molecule Tests	48
4 Segmentation of Europe Market by Application	49
4.1 Market Overview by Application	49
4.2 Bioavailability and Bioequivalence Studies	51
4.3 Pharmacokinetics (PK)	52
4.4 Pharmacodynamics (PD)	53
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)	54
4.6 Other Applications	55
5 Segmentation of Europe Market by Test Type	56
5.1 Market Overview by Test Type	56
5.2 Cell-based Assays	58
5.2.1 Bacterial Cell-based Assays	59
5.2.2 Viral Cell-based Assays	60
5.3 Virology Testing	61
5.3.1 In Vitro Virology Testing	62
5.3.2 In Vivo Virology Testing	63
5.3.3 Species-Specific Viral PCR Assays	64
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)	65
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies	66
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies	67
5.5 Method Development Optimization and Validation (MDOV)	68
5.6 Biomarker Testing	69
5.7 Pharmacokinetic Testing	70
5.8 Other Test Types	71
6 Segmentation of Europe Market by Workflow Process	72
6.1 Market Overview by Workflow Process	72
6.2 Sample Preparation	74
6.2.1 Protein Precipitation	75
6.2.2 Liquid-liquid Extraction (LLE)	76
6.2.3 Solid Phase Extraction (SPE)	77
6.3 Sample Analysis	78
6.3.1 Hyphenated Technique	80
6.3.2 Chromatographic Technique	81
6.3.3 Electrophoresis	82
6.3.4 Ligand Binding Assay	83
6.3.5 Mass Spectrometry	84
6.3.6 Nuclear Magnetic Resonance	85
6.4 Other Workflow Processes	86
7 Segmentation of Europe Market by Therapeutic Area	87
7.1 Market Overview by Therapeutic Area	87
7.2 Oncology	89
7.3 Neurology	90
7.4 Infectious Diseases	91
7.5 Gastroenterology	92
7.6 Cardiology	93
7.7 Other Therapeutic Areas	94
8 Segmentation of Europe Market by End User	95
8.1 Market Overview by End User	95
8.2 Pharma and Biopharma Companies	97
8.3 Contract Development and Manufacturing Organizations (CDMOs)	98
8.4 Contract Research Organizations (CROs)	99
9 European Market 2021-2031 by Country	100
9.1 Overview of European Market	100
9.2 Germany	103
9.3 U.K.	105
9.4 France	107
9.5 Spain	109
9.6 Italy	111
9.7 Russia	113
9.8 Rest of European Market	115
10 Competitive Landscape	117
10.1 Overview of Key Vendors	117
10.2 New Product Launch, Partnership, Investment, and M&A	120
10.3 Company Profiles	121
Charles River Laboratories International Inc.	121
Covance Inc.	123
Eurofins Scientific	124
ICON PLC	125
Intertek Group PLC	126
IQVIA Holdings, Inc.	127
Laboratory Corporation of America Holdings	128
Medpace Holdings, Inc.	129
Pace Analytical Services LLC.	130
Parexel International Corporation	131
PPD Inc.	132
SGS SA	133
Syneos Health, LLC	134
Toxikon Corporation	135
WuXi Apptech Co., Ltd.	136
RELATED REPORTS	137
List Of Tables:


Table 1.  Snapshot of Europe Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Health Spending by Region, $ bn, 2013-2020	27
Table 4.  Main Product Trends and Market Opportunities in Europe Bioanalytical Testing Services Market	34
Table 5. Europe Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn	42
Table 6. Europe Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn	45
Table 7. Europe Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	49
Table 8. Europe Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn	56
Table 9. Europe Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn	58
Table 10. Europe Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn	61
Table 11. Europe Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn	65
Table 12. Europe Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	72
Table 13. Europe Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn	74
Table 14. Europe Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn	79
Table 15. Europe Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	87
Table 16. Europe Bioanalytical Testing Services Market by End User, 2021-2031, $ mn	95
Table 17. Europe Bioanalytical Testing Services Market by Country, 2021-2031, $ mn	102
Table 18. Germany Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	104
Table 19. Germany Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	104
Table 20. Germany Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	104
Table 21. U.K. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	106
Table 22. U.K. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	106
Table 23. U.K. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	106
Table 24. France Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	108
Table 25. France Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	108
Table 26. France Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	108
Table 27. Spain Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	110
Table 28. Spain Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	110
Table 29. Spain Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	110
Table 30. Italy Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	112
Table 31. Italy Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	112
Table 32. Italy Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	112
Table 33. Russia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	114
Table 34. Russia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	114
Table 35. Russia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	114
Table 36. Bioanalytical Testing Services Market in Rest of Europe by Country, 2021-2031, $ mn	116
Table 37. Charles River Laboratories International Inc.: Company Snapshot	121
Table 38. Charles River Laboratories International Inc.: Business Segmentation	122
Table 39. Charles River Laboratories International Inc.: Product Portfolio	122
List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Europe Bioanalytical Testing Services Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6.  Leading Causes of Death in the World, 2019-2020, million	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	26
Figure 9. Primary Drivers and Impact Factors of Europe Bioanalytical Testing Services Market	28
Figure 10. Primary Restraints and Impact Factors of Europe Bioanalytical Testing Services Market	31
Figure 11. Investment Opportunity Analysis	35
Figure 12. Porter’s Fiver Forces Analysis of Europe Bioanalytical Testing Services Market	38
Figure 13. Breakdown of Europe Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue	43
Figure 14. Europe Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%)	43
Figure 15. Europe Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn	44
Figure 16. Europe Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn	45
Figure 17. Europe Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn	46
Figure 18. Europe Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn	47
Figure 19. Europe Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn	48
Figure 20. Breakdown of Europe Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue	50
Figure 21. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	50
Figure 22. Europe Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn	51
Figure 23. Europe Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn	52
Figure 24. Europe Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn	53
Figure 25. Europe Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn	54
Figure 26. Europe Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn	55
Figure 27. Breakdown of Europe Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue	57
Figure 28. Europe Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)	57
Figure 29. Europe Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn	58
Figure 30. Europe Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn	59
Figure 31. Europe Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn	60
Figure 32. Europe Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn	61
Figure 33. Europe Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn	62
Figure 34. Europe Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn	63
Figure 35. Europe Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn	64
Figure 36. Europe Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn	65
Figure 37. Europe Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	66
Figure 38. Europe Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	67
Figure 39. Europe Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn	68
Figure 40. Europe Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn	69
Figure 41. Europe Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn	70
Figure 42. Europe Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn	71
Figure 43. Breakdown of Europe Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue	73
Figure 44. Europe Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%)	73
Figure 45. Europe Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn	74
Figure 46. Europe Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn	75
Figure 47. Europe Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn	76
Figure 48. Europe Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn	77
Figure 49. Europe Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn	78
Figure 50. Europe Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn	80
Figure 51. Europe Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn	81
Figure 52. Europe Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn	82
Figure 53. Europe Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn	83
Figure 54. Europe Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn	84
Figure 55. Europe Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn	85
Figure 56. Europe Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn	86
Figure 57. Breakdown of Europe Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue	88
Figure 58. Europe Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)	88
Figure 59. Europe Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn	89
Figure 60. Europe Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn	90
Figure 61. Europe Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn	91
Figure 62. Europe Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn	92
Figure 63. Europe Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn	93
Figure 64. Europe Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn	94
Figure 65. Breakdown of Europe Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue	95
Figure 66. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	96
Figure 67. Europe Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn	97
Figure 68. Europe Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn	98
Figure 69. Europe Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	99
Figure 70. Breakdown of European Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue	101
Figure 71. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	102
Figure 72.  Bioanalytical Testing Services Market in Germany, 2021-2031, $ mn	103
Figure 73.  Bioanalytical Testing Services Market in U.K., 2021-2031, $ mn	105
Figure 74.  Bioanalytical Testing Services Market in France, 2021-2031, $ mn	107
Figure 75.  Bioanalytical Testing Services Market in Spain, 2021-2031, $ mn	109
Figure 76.  Bioanalytical Testing Services Market in Italy, 2021-2031, $ mn	111
Figure 77.  Bioanalytical Testing Services Market in Russia, 2021-2031, $ mn	113
Figure 78.  Bioanalytical Testing Services Market in Rest of Europe, 2021-2031, $ mn	115
Figure 79. Growth Stage of Europe Bioanalytical Testing Services Industry over the Forecast Period	117
Selected Key Players: 
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)